An Open Label, Phase 2a Clinical Trial for the Evaluation of Safety and Efficacy of RZL-012 for the Treatment of Women With Lipedema Involving Substantial Fat Above the Knee or of Women and Men With Nodular Dercum's Disease
Latest Information Update: 09 Sep 2019
At a glance
- Drugs RZL-012 (Primary)
- Indications Adiposis dolorosa; Lipoedema
- Focus Adverse reactions
- Sponsors Raziel Therapeutics
Most Recent Events
- 09 Sep 2019 New trial record